Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (361-370 of 416) with videos related to

Pageof 42
Sort By:
Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.
Journal of Visualized Experiments : Jove|May 23, 2022
Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue CollectionSafwan Alomari, Jayanidhi Kedda, Adarsha P Malla, et al.
Cancer|May 12, 2017
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinomaRobert R McWilliams, Nathan R Foster, Michelle R Mahoney, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Therapeutics|August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study GroupG Sussman, J Shurman, M R Creed, et al.
Neuro-Oncology|January 8, 2019
Radiation-induced astrocyte senescence is rescued by Δ133p53Casmir Turnquist, Jessica A Beck, Izumi Horikawa, et al.
Investigational New Drugs|August 31, 2002
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancerAlex A Adjei, Joel M Reid, Charles Erlichman, et al.
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumorsAlex A Adjei, Joel M Reid, Robert B Diasio, et al.
Pageof 42

Showing results (361-370 of 416) with videos related to

Sort By:
Pageof 42
Cancer Cell|August 4, 2009
Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorderKatherine I Oravecz-Wilson, Steven T Philips, Omer H Yilmaz, et al.
Journal of Visualized Experiments : Jove|May 23, 2022
Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue CollectionSafwan Alomari, Jayanidhi Kedda, Adarsha P Malla, et al.
Cancer|May 12, 2017
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinomaRobert R McWilliams, Nathan R Foster, Michelle R Mahoney, et al.
Journal of Neuro-Oncology|February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent gliomaS V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Therapeutics|August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study GroupG Sussman, J Shurman, M R Creed, et al.
Neuro-Oncology|January 8, 2019
Radiation-induced astrocyte senescence is rescued by Δ133p53Casmir Turnquist, Jessica A Beck, Izumi Horikawa, et al.
Investigational New Drugs|August 31, 2002
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancerAlex A Adjei, Joel M Reid, Charles Erlichman, et al.
Molecular Cancer Therapeutics|April 17, 2008
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomyJudith A Gilbert, Matthew P Goetz, Carol A Reynolds, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumorsAlex A Adjei, Joel M Reid, Robert B Diasio, et al.
Pageof 42